3-(2-phenylethyl)-4-methylsydnone has been researched along with 3-(2-(2-4-6-trimethylphenyl)thioethyl)-4-methylsydnone* in 1 studies
1 other study(ies) available for 3-(2-phenylethyl)-4-methylsydnone and 3-(2-(2-4-6-trimethylphenyl)thioethyl)-4-methylsydnone
Article | Year |
---|---|
Effects of 3-(2-phenylethyl)-4-methylsydnone and related sydnones on heme biosynthesis.
3-[2-(2,4,6-Trimethylphenyl)thioethyl]-4-methylsydnone (TTMS) and 3-(2-phenylethyl)-4-methylsydnone (PEMS) cause mechanism-based inactivation of rat hepatic microsomal cytochrome P-450 and the formation of N-alkylprotoporphyrins in rat liver. In the present study, we have shown that both TTMS and PEMS cause mechanism-based inactivation of chick embryo hepatic microsomal cytochrome P-450. TTMS also caused the inhibition of ferrochelatase activity, the accumulation of protoporphyrin IX, and an increase in the activity of delta-aminolevulinic acid synthase in chick embryo liver cell culture. PEMS was devoid of effect on ferrochelatase activity, porphyrin accumulation, and delta-aminolevulinic acid synthase activity. There are two possible explanations for the lack of effect of PEMS on heme biosynthesis: (1) the ring-A- and/or ring-B-substituted regiosomers of the N-phenylethyl- and N-phenylethenylprotoporphyrins which are produced during the mechanism-based inactivation of cytochrome P-450 by PEMS are too bulky to fit into the active site of ferrochelatase to inhibit its activity, in contrast to the N-vinylprotoporphyrin formed from TTMS; and (2) the N-alkylprotoporphyrins produced consist of the ring-C- and/or ring-D-substituted regioisomers, which are not inhibitors of ferrochelatase activity. Topics: 5-Aminolevulinate Synthetase; Animals; Cells, Cultured; Chick Embryo; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Ferrochelatase; Heme; Liver; Microsomes, Liver; Molecular Structure; Oxadiazoles; Porphyrins; Sydnones | 1990 |